EyePoint Pharmaceuticals
EYPT
EYPT
145 hedge funds and large institutions have $553M invested in EyePoint Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.25% less ownership
Funds ownership: 109.3% → 109.06% (-0.25%)
7% less call options, than puts
Call options by funds: $2.28M | Put options by funds: $2.46M
Holders
145
Holding in Top 10
3
Calls
$2.28M
Puts
$2.46M
Top Buyers
| 1 | +$23.7M | |
| 2 | +$19.7M | |
| 3 | +$14.6M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13.3M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$12M |
Top Sellers
| 1 | -$8.74M | |
| 2 | -$7.98M | |
| 3 | -$7.91M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.66M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.24M |